Bullish option flow detected in tempus AI ( TEM) Inc Class A with 59,111 calls trading, 4x expected, and implied vol increasing almost 6 points to 93.24%. 2/14 weekly 80 calls and Feb-25 85 calls are ...

We recently compiled a list of the 10 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...

Tempus AI (TEM) announced a new collaboration with the Institute for Follicular Lymphoma Innovation. The collaboration aims to develop and make ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Refusing to slow down since the start of the new year, shares of Tempus AI (NASDAQ: TEM) have skyrocketed nearly 99% since ...

Fintel reports that on February 12, 2025, William Blair downgraded their outlook for Tempus AI (NasdaqGS:TEM) from Outperform to Market Perform. Analyst Price Forecast Suggests 18.51% Downside As of ...

We recently compiled a list of the 10 Large-Cap Stocks Insiders Are Selling Recently. In this article, we are going to take a ...

William Blair downgraded Tempus AI Inc (NASDAQ:TEM) to "Market Perform" from "Outperform" given stock's sharp rally rather than any concerns over the company’s fundamentals. Tempus shares have surged ...

AI hyperscalers are spending billions of dollars on data centers. The result could be a decade of prosperity for long-term investors.

William Blair downgraded Tempus AI (TEM) to Market Perform from Outperform without a price target The firm cites valuation for the downgrade ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, recently announced it has completed its acquisition of Ambry Genetics, a ...